Vitamin D and Non-Hodgkin Lymphoma Risk in Adults: A Review
Authors:
Jennifer L. Kelly a;
Jonathan W. Friedberg b;
Laura M. Calvi c;
Edwin van Wijngaarden a;
Susan G. Fisher a
| Affiliations: | a Department of Community and Preventive Medicine, University of Rochester, Rochester, New York, USA |
| b James P. Wilmot Cancer Center, University of Rochester, Rochester, New York, USA | |
| c Endocrine Metabolism Division, Department of Medicine, University of Rochester, Rochester, New York, USA |
DOI:
10.3109/07357900902849632
Publication Frequency:
10 issues per year
Subject:
Oncology;
Formats available:
PDF
(English)
View Article:
View Article (PDF)
Abstract
Animal and human studies support a protective effect of vitamin D sufficiency related to malignancy by uncovering paracrine and autocrine effects of extra-renal 25-hydroxyvitamin D (25(OH)D) activation including regulation of cell cycle proliferation, apoptosis induction, and increased cell differentiation signaling. Recent epidemiologic studies demonstrate a reduction in non-Hodgkin lymphoma (NHL) risk with increased sunlight exposure. As sunlight is a major vitamin D source, it has been suggested that vitamin D status may mediate this observed association. This review provides a comprehensive discussion of the current epidemiologic evidence with regard to the investigation of an association between vitamin D status and NHL risk.
|


Download Citation

CiteULike
Del.icio.us
BibSonomy
Connotea